Similar effects have been observed in MPTP mouse models of PD with D-Ala2-GIP-glu-PAL reducing inflammation, oxidative stress, lipid peroxidation, and -synuclein levels, whilst protecting dopaminergic neurons in the substantia nigra [107]
Sherwood RI, Christensen JL, Conboy IM, Conboy MJ, Rando TA, Weissman IL, et al
BPC-157 provides researchers with a consistent tool for exploring peptide behavior in laboratory systems focused on structural and cellular dynamics
Marcus, R
1 REIMAGINE 2 was a 68-week phase 3 trial evaluating the safety and efficacy of CagriSema in doses 2.4 mg/2.4 mg and 1 mg/1 mg once weekly versus semaglutide 2.4 mg, semaglutide 1 mg, cagrilintide 2.4 mg, and dose-matched placebo in 2,713 adults with T2D inadequately controlled with metformin with or without an SGLT2 inhibitor
PMID: 16558432